Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Current Diabetes Reports|May 29, 2012
Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathyGeorge Bayliss, Larry A Weinrauch, John A D'EliaAmerican Journal of Physiology. Renal Physiology|December 21, 2012
EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injurySong He, Na Liu, George Bayliss, et al.Frontiers in Pharmacology|November 22, 2021
New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney DiseaseMinghai Shao, Chaoyang Ye, George Bayliss, et al.Current Diabetes Reports|June 27, 2014
Resistant hypertension in diabetes mellitusGeorge Bayliss, Larry A Weinrauch, John A D'EliaAmerican Journal of Physiology. Renal Physiology|October 5, 2020
Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injuryWei Zhang, Yinjie Guan, George Bayliss, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 17, 2021
Kidney Disease among People Who Are IncarceratedMatthew Murphy, Ann Ding, Justin Berk, et al.Clinical Kidney Journal|June 16, 2017
Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximabBasma Merhi, Nikunjkuma Patel, George Bayliss, et al.Cell Death & Disease|March 31, 2025
SET8 inhibition preserves PTEN to attenuate kidney cell apoptosis in cisplatin nephrotoxicityXu Yang, Yingjie Guan, George Bayliss, et al.Clinical Kidney Journal|September 29, 2016
Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a reviewJohn A D'Elia, George Bayliss, Ray E Gleason, et al.Research Square|August 26, 2024
SET8 inhibition preserves PTEN to attenuate kidney cell apoptosis in cisplatin nephrotoxicityXu Yang, Yingjie Guan, George Bayliss, et al.Pageof 6